These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3338272)

  • 1. Patients with CLL and hypocomplementaemia have an impaired serum bactericidal activity against the Salmonella minnesota Re mutant.
    Varga L; Clas F; Füst G; Pálóczi K; Szegedi G; Loos M; Hollán SR
    Complement; 1988; 5(1):40-5. PubMed ID: 3338272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F; Loos M
    Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of human sera with a physiologic or genetic defect of the complement system.
    Jankowski S; Grzybek-Hryncewicz K; Kopeć W; Zalewski J; Zielinsk SA
    Acta Microbiol Pol; 1988; 37(3-4):309-15. PubMed ID: 2470241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective complement activity in chronic lymphocytic leukemia.
    Heath ME; Cheson BD
    Am J Hematol; 1985 May; 19(1):63-73. PubMed ID: 3845763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bactericidal and opsonic activities in chronic lymphocytic leukemia and multiple myeloma.
    Kansu E; Akalin E; Civelek C; Tekesin O; Laleli Y; Firat D
    Am J Hematol; 1986 Nov; 23(3):191-6. PubMed ID: 3766522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro.
    Repine JE; Clawson CC; Friend PS
    J Clin Invest; 1977 May; 59(5):802-9. PubMed ID: 323290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
    J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL).
    Day NK; Winfield JB; Gee T; Winchester R; Teshima H; Kunkel HG
    Clin Exp Immunol; 1976 Nov; 26(2):189-95. PubMed ID: 136325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemia.
    Miszlai Z; Czink E; Varga L; Pálóczi K; Szegedi G; Füst G; Hollán SR
    Acta Med Hung; 1986; 43(4):389-95. PubMed ID: 3601584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase-induced hypocomplementemia in acute lymphocytic leukemia (ALL) of childhood.
    Shapiro R; Kim Y; Michael AF; Gerrard JM; Nesbit M; Coccia P; Ramsay NK; Krivit W
    Am J Pediatr Hematol Oncol; 1979; 1(1):5-7. PubMed ID: 295575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of serum for Klebsiella rhinoscleromatis: studies on serum from a patient with rhinoscleroma and sera deficient in antibody or complement.
    North ME; Newton CA; Wright DJ; Webster AD
    J Med Microbiol; 1982 May; 15(2):267-72. PubMed ID: 6754946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of C2 and C4 in sera from hamsters bearing herpes simplex type 2-induced tumors.
    Márquez ED
    Immunol Commun; 1980; 9(6):569-75. PubMed ID: 7429530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance.
    Füst G; Miszlay Z; Czink E; Varga L; Pálóczi K; Szegedi G; Hollán SR
    Immunol Lett; 1987 Feb; 14(3):255-9. PubMed ID: 3570363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement component deficiency and autoimmune diseases].
    Sela O; Shoenfeld Y
    Harefuah; 1988 Sep; 115(5-6):129-34. PubMed ID: 3056794
    [No Abstract]   [Full Text] [Related]  

  • 16. A new haemolytic assay for the second component of complement (C2) in human serum.
    Naish PF; Barratt J; Collins C
    Clin Exp Immunol; 1976 Sep; 25(3):487-9. PubMed ID: 963910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic deficiency of complement (author's transl)].
    Hauptmann G
    Nouv Presse Med; 1978 Nov; 7(38):3443-7. PubMed ID: 310996
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complement system in glomerulonephritis. II. Detailed aspects].
    Bodalski J; Narebska E; Jerzmanowski A
    Pediatr Pol; 1980 Jun; 55(6):805-11. PubMed ID: 7413331
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired bactericidal activity of cord sera against Salmonella strains.
    Jankowski S; Konrad A; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1983; 31(2):249-53. PubMed ID: 6360075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemia.
    Varga L; Miszlay Z; Czink E; Pálóczi K; Szegedi G; Füst G; Hollán SR
    Diagn Clin Immunol; 1987; 5(3):129-34. PubMed ID: 3319280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.